Haleon (NYSE:HLN) Stock Rating Upgraded by Argus

Haleon (NYSE:HLN) was upgraded by stock analysts at Argus to a “strong-buy” rating in a note issued to investors on Tuesday,Zacks.com reports.

A number of other research firms have also recently weighed in on HLN. Morgan Stanley reissued an “overweight” rating on shares of Haleon in a research note on Monday, December 15th. HSBC upgraded shares of Haleon from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, January 21st. Deutsche Bank Aktiengesellschaft cut shares of Haleon from a “hold” rating to a “sell” rating in a research report on Monday, January 12th. Jefferies Financial Group reaffirmed a “buy” rating on shares of Haleon in a research note on Tuesday, January 20th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Haleon in a research note on Thursday, January 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, four have given a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Haleon presently has a consensus rating of “Moderate Buy” and an average target price of $12.33.

Haleon Stock Up 1.3%

HLN stock opened at $10.60 on Tuesday. The company has a market cap of $47.19 billion, a PE ratio of 27.17 and a beta of 0.18. The company has a quick ratio of 0.71, a current ratio of 0.92 and a debt-to-equity ratio of 0.47. Haleon has a twelve month low of $8.71 and a twelve month high of $11.42. The business’s 50-day simple moving average is $10.52 and its 200 day simple moving average is $9.87.

Institutional Investors Weigh In On Haleon

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. SOA Wealth Advisors LLC. raised its holdings in Haleon by 60.5% during the third quarter. SOA Wealth Advisors LLC. now owns 3,105 shares of the company’s stock worth $28,000 after acquiring an additional 1,170 shares in the last quarter. Citizens National Bank Trust Department lifted its stake in shares of Haleon by 167.4% during the 3rd quarter. Citizens National Bank Trust Department now owns 3,276 shares of the company’s stock worth $29,000 after buying an additional 2,051 shares during the last quarter. Parkside Financial Bank & Trust boosted its holdings in shares of Haleon by 101.3% during the fourth quarter. Parkside Financial Bank & Trust now owns 2,847 shares of the company’s stock worth $29,000 after acquiring an additional 1,433 shares during the period. Atlantic Union Bankshares Corp boosted its holdings in shares of Haleon by 293.7% during the third quarter. Atlantic Union Bankshares Corp now owns 3,697 shares of the company’s stock worth $33,000 after acquiring an additional 2,758 shares during the period. Finally, Stance Capital LLC acquired a new position in Haleon in the 3rd quarter valued at $34,000. 6.67% of the stock is owned by institutional investors.

About Haleon

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.